Closing of this transformative transaction expected in early Q2 2020 upon completion of remaining closing conditions and receipt of regulatory approval in IsraelRALEIGH NC ACCESSWIRE February 18 2020 Innovate Biopharmaceuticals Inc. Nasdaq INNT &qu...
↧